← Back to Entity Graph

Hudson Institute of Medical Research

Concentration Risk
FoundationRegistryHPCABN 48132025024VIC
Relationships
32
Data Sources
2
Revenue
$64.3M
Tax Payable
Preview
Data as of: 17 June 2026
Found in 2 systemsACNC CharitiesFoundations

About

Hudson Institute of Medical Research is an Australian translational medical research institute focused on advancing discovery science and clinical applications in inflammation, cancer, and women's and newborn health. Located at Monash Health Translation Precinct in Victoria, the institute conducts research into chronic inflammatory diseases, infectious diseases, and cancer, with a mission to develop new diagnostic and treatment approaches for conditions affecting millions globally.

Giving Philosophy

Hudson Institute supports translational medical research that bridges discovery science with clinical application, prioritizing areas where chronic inflammation and cancer significantly impact human health. The institute appears to value innovative approaches to diagnosis and treatment development, with emphasis on conditions that are either under-diagnosed or represent major global health burdens.

Wealth Source:Medical research institute funded through research grants, philanthropic donations, government funding (including NHMRC), and legacy giving programs.

Tips for Applicants

Prospective partners should align research proposals with Hudson's core focus areas of inflammation, cancer, or women's and newborn health, and demonstrate translational potential from bench to clinical application. Researchers should consider the institute's emphasis on addressing globally significant health burdens and under-diagnosed conditions.

Financial History (7 years)

YearRevenueExpensesAssetsSurplus
2023$64.3M$63.7M$53.5M$594K
2022$58.3M$57.2M$50.9M$1.1M
2021$58.9M$58.0M$50.7M$855K
2020$53.9M$52.7M$42.0M$1.2M
2019$49.4M$49.3M$35.8M$125K
2018$47.7M$47.8M$31.0M$-94,105
2017$42.8M$43.1M$30.1M$-391,866
Govt Revenue
$40.7M
0
Staff (FTE)
221
Volunteers
20
Donations Received
$9.1M

Community Evidence

External Evidence

Identity

GS ID
AU-ABN-48132025024
ABN
48132025024
Sector
health
Financial Year
2023

Focus Areas

Themes
healthresearch
Geography
AU-VICAU-National
Target Recipients
research institutionsmedical researchersacademic institutions
Purposes
Health
Beneficiaries
AdultsAgedChildrenEarly ChildhoodChronic Illness

Board & Leadership (8)

  • Robert Edgar
    chair
  • Andrew Leyden
    director
  • Christina Mitchell
    director
  • Christopher Dodd
    director
  • George Ou
    director
  • Jill Hennessy
    director
  • Warwick Anderson
    director
  • Robert Merriel
    secretary

Financials

Revenue
$64.3M
Assets
$53.5M

Method

Match Confidence
registry
Cross-references
2 datasets
Match Key
ABN
Relationships
32

Matched by Australian Business Number (ABN) — high confidence. This entity was found across multiple government datasets using the same ABN.

Data Sources

ACNCFoundations

JusticeHub

External Link

This entity is also tracked in JusticeHub with 0 interventions and 0 evidence records.

External ecosystem profile linked from GrantScope for additional context. JusticeHub content is maintained separately.

View on JusticeHub

Location Intelligence

Postcode
3168
Locality
CLAYTON
Remoteness
Major Cities of Australia
SEIFA Disadvantage
Decile 4/10
LGA
Monash
Entities in Area
459
View on Power Map